17.03.2018 • NewsBiotechnologyCRBM+W

David Estapé to Join CRB Group as Technology Manager Biotechnology

David Estapé will join CRB Group from M+W Group as Technology Manager...
David Estapé will join CRB Group from M+W Group as Technology Manager Biotechnology

David Estapé, a long-time biotechnology expert who holds a doctorate in chemical engineering and has 22 years of experience, will join CRB Group as  Technology Manager Biotechnology and will be based in Basel, Switzerland.

Currently Technology Manager Life Sciences at M+W Group, an international plant engineering firm, Estapé has worked on major biotech projects globally, driven biotech strategy internally, gained experience in GMP and facility design for biopharma, and participated heavily in organizations like the International Society for Pharmaceutical Engineering (ISPE), BioPhorum Operations Group and Parenteral Drug Association. 

Estapé studied Chemical Engineering at the Autonomous University of Barcelona (UAB) and received his degree in 1989. After an Erasmus exchange study at the Technical University Delft (NL) he did his PhD research at the GBF (Gesellschaft für Biotechnologische Forschung) in Braunschweig, Germany. In 1996 he received his PhD degree from the UAB and joined Life Sciences Meissner + Wurst (LSMW), a German life sciences solutions provider that later became part of M+W Group. Starting as junior engineer, in his 22-year career at M+W Estapé held various positions and eventually became Technology Manager in the global business unit Life Sciences and Chemicals.

Estapé’s major focus at CRB will be to provide CRB’s clients with expertise in biotechnology front-end engineering, process technologies, regulatory/Good Manufacturing Practice, advanced facility design and strategic planning. While he will be based in Basel, Estapé will be available to support all 15 of CRB’s offices and enhance CRB’s existing capabilities in the biotechnology market.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.